Ella Ye – Page 11 – Asian Fund for Cancer Research

Asian Fund for Cancer Research Announces Inaugural 2020 BRACE Award Venture Competition Winner

07/04/2021AFCR News

FOR IMMEDIATE RELEASE: 7 April 2021 CONTACTS: Asian Fund for Cancer Research Bradley Gillenwater, Senior Director for Corporate Engagement E-mail: bgillenwater@afcr.org Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: marco.raccuia@hugillandip.com Asian Fund for Cancer Research Announces Inaugural BRACE Award Venture Competition Winner Gastrointestinal Cancer Drug Developer Arbele Receives…

Therapeutic Vaccines Showed Long-term Anti-Cancer Effects for Melanoma

31/03/2021Global Cancer News

When people hear the word “vaccine”, they often think about vaccine’s preventive function that protects people from getting infectious diseases such as flu, hepatitis or Covid-19. It’s true that traditional vaccines are developed to prevent infectious diseases, but innovative scientists are developing…

The Benefits of Juicing: Fact vs Fiction

31/03/2021AFCR News, Cancer Prevention & Treatments

No matter who you are or where you live, everyone can benefit by following one simple rule: eat more vegetables! But is juicing also beneficial? To keep it simple, the Asian Fund for Cancer Research has broken down some myths and spelled…

Alcohol and Cancer

30/03/2021AFCR News, Cancer Prevention & Treatments

Which cancers are related to alcohol usage? The more alcohol one drinks, the higher their risk of cancer. Alcohol intake has been proven to be directly correlated with cancers of the mouth, throat, larynx, esophagus, liver, colon, rectum, and of course, breast. It…

Applications Open for the 2021 AIM-HI Women’s Venture Competition!

17/03/2021AFCR News, WVC

Working with our strategic partners, the National Foundation for Cancer Research and AIM-HI Accelerator Fund (AIM-HI), AFCR have launched the inaugural Women’s Venture Competition in 2020. The AIM-HI Women’s Venture Competition is a first-of-its-kind program that combines extensive coaching, networking and financial…

Therapeutics – anticancer system capable of loco-regional delivery of drug product

12/03/2021Uncategorized

Privo Technologies, Inc. is focused on changing the oncology treatment paradigm with its Programmed Release Vehicle (PRV) technology.

Therapeutics – Anticancer System Capable of Loco-regional Delivery of Drug Product

12/03/2021Early Detection and Prevention, Innovative Therapies and Treatments, Women-Led Research Projects

Innovation: Therapeutics – anticancer system capable of loco-regional delivery of drug product Targeted Cancer(s): Solid Tumors, Mucosal Cancers. Initial indication: Oral Cancer Scientific Leadership/Leadership: Manijeh Goldberg, PhD., President & CEO; James Mackay, PhD., Board Member and Chief Advisor; Nishant Agrawal, MD., Chief Medical Advisor Stage…

3 Things to Know Before Getting the Covid-19 Vaccine

08/03/2021AFCR News

A fast vaccination will push the world entering the stage of herd immunity, namely enough population will have gained immune protection against the COVID-19 virus and the infection will no longer be able to spread easily. Unlike healthy people, cancer patients need to…

Cancer Fighting Foods: Carrots

28/02/2021Cancer Prevention & Treatments

Though there is not yet a 100% effective way to prevent all types of cancer, there have been amazing discoveries regarding ways in which certain foods can aid in prevention. Carrots have long been in the public eye as an excellent way…

Lymphoma is Largely Gone After Covid-19 Infection: Demonstrating the Power of the Immune System

28/02/2021AFCR News

A 61‐year‐old man with stage III Hodgkin lymphoma was hospitalized for the infection of Covid-19 in the UK. He was hospitalized for 11 days and did not receive any cancer treatment. Four months later, the PET-CT scan result showed that his lymphoma…

Author page: Ella Ye